iRhythm Technologies Inc. (IRTC) Financial Statements (2024 and earlier)

Company Profile

Business Address 699 8TH STREET
SAN FRANCISCO, CA 94103
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:110,185128,435131,670130,378158,575157,032
Short-term investments97,591110,995103,161123,533134,312132,316
Other undisclosed cash, cash equivalents, and short-term investments12,59417,44028,5096,84524,26324,716
Receivables61,48450,06751,10849,55749,91860,534
Inventory, net of allowances, customer advances and progress billings13,97313,64814,47816,38815,15514,452
Inventory13,97313,64814,47816,38815,15514,452
Other undisclosed current assets45,17042,14244,88557,56765,12453,832
Total current assets:230,812234,292242,141253,890288,772285,850
Noncurrent Assets
Operating lease, right-of-use asset49,31760,89957,91759,30160,66662,010
Property, plant and equipment104,11496,66889,84582,20875,67071,515
Intangible assets, net (including goodwill)862862862862862862
Goodwill862862862862862862
Restricted cash and investments      
Other noncurrent assets48,03947,04838,72325,44022,25220,153
Total noncurrent assets:202,332205,477187,347167,811159,450154,540
TOTAL ASSETS:433,144439,769429,488421,701448,222440,390
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities88,90583,84371,61964,38573,014108,128
Employee-related liabilities40,460
Accounts payable5,5437,2127,1509,7787,5177,404
Accrued liabilities83,36276,63164,46954,60765,49760,264
Deferred revenue3,3063,3833,6953,4863,0513,003
Other undisclosed current liabilities15,15915,06514,09914,03213,031(27,540)
Total current liabilities:107,370102,29189,41381,90389,09683,591
Noncurrent Liabilities
Long-term debt and lease obligation34,95034,94634,94234,93934,935116,412
Long-term debt, excluding current maturities34,95034,94634,94234,93934,93534,931
Liabilities, other than long-term debt80,72782,73781,25483,02584,3791,163
Other liabilities1,0121,0131,0121,0131,3071,163
Operating lease, liability79,71581,72480,24282,01283,07281,481
Total noncurrent liabilities:115,677117,683116,196117,964119,314117,575
Total liabilities:223,047219,974205,609199,867208,410201,166
Equity
Equity, attributable to parent210,097219,795223,879221,834239,812239,224
Common stock313130302828
Treasury stock, value      
Additional paid in capital855,784826,686803,792783,182762,380741,879
Accumulated other comprehensive loss(112)(15)(152)(69)(396)(681)
Accumulated deficit(645,606)(606,907)(579,791)(561,309)(522,200)(502,002)
Total equity:210,097219,795223,879221,834239,812239,224
TOTAL LIABILITIES AND EQUITY:433,144439,769429,488421,701448,222440,390

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues132,511124,604124,130111,436112,617103,875
Cost of revenue(45,085)(42,130)(37,905)(35,755)(33,910)(32,954)
Gross profit:87,42682,47486,22575,68178,70770,921
Operating expenses(126,608)(110,077)(105,097)(115,185)(99,405)(92,007)
Operating loss:(39,182)(27,603)(18,872)(39,504)(20,698)(21,086)
Nonoperating income
(Other Nonoperating income)
   1,4321,586365
Interest and debt expense(941)(927)(832)(950)(1,013)(614)
Other undisclosed income from continuing operations before equity method investments, income taxes 6,155     
Loss from continuing operations before equity method investments, income taxes:(33,968)(28,530)(19,704)(39,022)(20,125)(21,335)
Other undisclosed income (loss) from continuing operations before income taxes (4,476)1,6091,435   
Loss from continuing operations before income taxes:(38,444)(26,921)(18,269)(39,022)(20,125)(21,335)
Income tax expense(255)(195)(213)(87)(73)(116)
Loss from continuing operations:(38,699)(27,116)(18,482)(39,109)(20,198)(21,451)
Loss before gain (loss) on sale of properties:(21,451)
Net loss available to common stockholders, diluted:(38,699)(27,116)(18,482)(39,109)(20,198)(21,451)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net loss:(38,699)(27,116)(18,482)(39,109)(20,198)(21,451)
Comprehensive loss:(38,699)(27,116)(18,482)(39,109)(20,198)(21,451)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(97)137(83)327285(98)
Comprehensive loss, net of tax, attributable to parent:(38,796)(26,979)(18,565)(38,782)(19,913)(21,549)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: